Zobrazeno 1 - 10
of 14
pro vyhledávání: '"L.M.H. Schack"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cai Grau, L.M.H. Schack, Jens Overgaard, Kenneth Jensen, Jan Alsner, Boe Sandahl Sorensen, Pernille Lassen, Jesper Grau Eriksen, Christian Rønn Hansen, Christian Nicolaj Andreassen
Publikováno v:
Andreassen, C N, Eriksen, J G, Jensen, K, Hansen, C R, Sørensen, B S, Lassen, P, Alsner, J, Schack, L M H, Overgaard, J & Grau, C 2018, ' IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer ', Oral Oncology, vol. 86, pp. 91-99 . https://doi.org/10.1016/j.oraloncology.2018.09.001
Radiotherapy (RT) is an integral component in the management of head and neck cancer. Despite progress in several respects, a noteworthy proportion of the treated patients do not achieve complete response after RT. Regardless of novel dose delivery t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee4eadf3bf11997fdc8230bc7cc795d
https://pure.au.dk/portal/da/publications/imrt--biomarkers-for-dose-escalation-dose-deescalation-and-personalized-medicine-in-radiotherapy-for-head-and-neck-cancer(8fba50f9-c344-4310-9ccc-8dd174184653).html
https://pure.au.dk/portal/da/publications/imrt--biomarkers-for-dose-escalation-dose-deescalation-and-personalized-medicine-in-radiotherapy-for-head-and-neck-cancer(8fba50f9-c344-4310-9ccc-8dd174184653).html
Autor:
L Lundby, S.E. Petersen, Steffen Nielsen, Jens Overgaard, Morten Høyer, Jan Alsner, Christian Nicolaj Andreassen, Lise Bentzen, L.M.H. Schack
Publikováno v:
Schack, L M H, Petersen, S E, Nielsen, S, Lundby, L, Høyer, M, Bentzen, L, Overgaard, J, Andreassen, C N & Alsner, J 2017, ' Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients ', Acta Oncologica, vol. 56, no. 11, pp. 1514-1521 . https://doi.org/10.1080/0284186X.2017.1348626
INTRODUCTION:Normal tissue morbidity sets the dose limit for radiotherapy (RT) in cancer treatment and has importance for quality of life for cancer survivors. A previous study of prostate cancer patients treated with RT generated clinical data for r
Autor:
Jan Alsner, L.M.H. Schack, Christian Nicolaj Andreassen, Birgitte Vrou Offersen, Jens Overgaard
Publikováno v:
Schack, L M H, Alsner, J, Overgaard, J, Andreassen, C N & Offersen, B V 2016, ' Radiation-induced morbidity evaluated by high-frequency ultrasound ', Acta Oncologica, vol. 55, no. 12, pp. 1498-1500 . https://doi.org/10.1080/0284186X.2016.1222079
To the Editor,Radiotherapy (RT) is an important part of curative treatment for early breast cancer. A focus on the radiation-induced morbidity after RT in breast cancer survivors is justified by th...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac3082cd515cd7b3b58c08c9f55d8d5
https://pure.au.dk/ws/files/108600263/Schack_Acta_Oncol_2016_accepted_manuscript.pdf
https://pure.au.dk/ws/files/108600263/Schack_Acta_Oncol_2016_accepted_manuscript.pdf
Publikováno v:
Radiotherapy and Oncology. 127:S247-S248
Autor:
J.G. Eriksen, Craig Luccarini, L.M.H. Schack, Alison M. Dunning, Jan Alsner, Laura Fachal, Christian Nicolaj Andreassen, Leila Dorling, Jens Overgaard
Publikováno v:
Radiotherapy and Oncology. 127:S249-S250
Publikováno v:
Andreassen, C N, Schack, L M H, Laursen, L V & Alsner, J 2016, ' Radiogenomics-current status, challenges and future directions ', Cancer Letters, vol. 382, no. 1, pp. 127-136 . https://doi.org/10.1016/j.canlet.2016.01.035
Radiogenomics designates a scientific field that addresses possible associations between genetic germline alterations and normal tissue toxicity after radiotherapy. The ultimate aim of this research is to establish a gene-based predictive test for no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f321a20110549acf4d76c652b3bcef2a
https://pure.au.dk/portal/da/publications/radiogenomics--current-status-challenges-and-future-directions(04378d87-6765-462b-890d-9995f660d5f4).html
https://pure.au.dk/portal/da/publications/radiogenomics--current-status-challenges-and-future-directions(04378d87-6765-462b-890d-9995f660d5f4).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Schack, L M H, Mouritsen, L S, Mouritsen, L S, Krarup-Hansen, A & Safwat, A A 2015, ' The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia ', Acta Oncologica, vol. 54, no. 1, pp. 34-40 . https://doi.org/10.3109/0284186X.2014.958530
Background. Trabectedin was in Europe approved for treatment of metastatic soft tissue sarcoma (STS) in 2007 based on results of a phase II study with relatively few patients. The purpose of this nationwide retrospective study was to assess efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c99c369ad56c6291be771f4da170a8
https://pure.au.dk/portal/da/publications/the-danish-experience-with-trabectedin-treatment-for-metastatic-sarcoma-importance-of-hyponatremia(bfdc8431-ef18-4853-84e2-a1ef1d439400).html
https://pure.au.dk/portal/da/publications/the-danish-experience-with-trabectedin-treatment-for-metastatic-sarcoma-importance-of-hyponatremia(bfdc8431-ef18-4853-84e2-a1ef1d439400).html
Autor:
Jan Alsner, S.E. Petersen, Christian Nicolaj Andreassen, Lilli Lundby, Morten Høyer, L.M.H. Schack, Lise Bentzen, Jens Overgaard
Publikováno v:
Radiotherapy and Oncology. 115:S42-S43